paper_id,claim,figure_id,title,caption,local_image_path,url
PMC9255790,The current allograft manufacturing processes are summarised in Figure 1.,PMC9255790_figure_1,Figure 1. The conventional manufacturing processes and clinical applications of bone allografts. 3D: three-dimensional; UV: ultraviolet.,,./data/PMC9255790/images/figure_1.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/0bc24f923777/bt-03-01-65-g001.jpg
PMC9255790,"Open in a new tabSince 2000, 29,435 journal articles in PubMed were titled with the keywords ‘mesenchymal stem cells’, a steady increase from 24 articles in the year 2000 to 2571 in 2021 (Figure 2).",PMC9255790_figure_2,Figure 2. The number of journal article publications with the keywords ‘mesenchymal stem cells’ in their titles between 2000-2021 in PubMed index.,,./data/PMC9255790/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/a2c62e1ef8a0/bt-03-01-65-g002.jpg
PMC9255790,There have been in total 206 patents issued by the US Patent Office (https://patft.uspto.gov/netahtml/PTO/search-bool.html) titled with the keywords of ‘mesenchymal stem cells’ (Figure 3).,PMC9255790_figure_3,Figure 3. The US patents granted with the keywords ‘mesenchymal stem cells’ in the title.,,./data/PMC9255790/images/figure_3.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/e9f6e4f38f77/bt-03-01-65-g003.jpg
PMC9255790,"Open in a new tabBy searching clinical trials registered at the US National Library of Medicine (clinicaltrials.gov) that currently contains 401,145 research studies in 50 states in the US and 220 countries all over the world, we identified 1389 studies on ‘MSCs’ (Figure 4).62-64 Among these clinical trials, 421 studies were completed, yet only 10 products were approved for clinical application worldwide (Table 5) and no products were approved by the FDA in the US.",PMC9255790_figure_4,Figure 4. The number of clinical trials registered in the ClinicalTrials.gov with the keywords ‘mesenchymal stem cells’ in the title.,,./data/PMC9255790/images/figure_4.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/9c2219b919ad/bt-03-01-65-g004.jpg
PMC9255790,We propose that artificial bone allografts can be an immediate replacement for conventional bone allografts (Figure 5).,PMC9255790_figure_5,"Figure 5. The proposed manufacturing process. Scaffold is produced, then seeded with cells. When these cells osteogenically differentiate they will express growth factors such as BMP, which will remain on the scaffold after decellularisa-tion. 3D: three-dimensional; BMP: bone morphogenic proteins.",,./data/PMC9255790/images/figure_5.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/b94375d4374b/bt-03-01-65-g005.jpg
PMC9255790,"The prospective manufacturing process shown in Figure 5 can be as follows:

Scaffold selection: biodegradable porous scaffold composed of amorphous hydroxyapatite, calcium carbonate, collagen/gelatine and fabricated at near body temperature, ideally through 3D printing.",PMC9255790_figure_5,"Figure 5. The proposed manufacturing process. Scaffold is produced, then seeded with cells. When these cells osteogenically differentiate they will express growth factors such as BMP, which will remain on the scaffold after decellularisa-tion. 3D: three-dimensional; BMP: bone morphogenic proteins.",,./data/PMC9255790/images/figure_5.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/b94375d4374b/bt-03-01-65-g005.jpg
PMC9255790,"Since 2000, 29,435 journal articles in PubMed were titled with the keywords ‘mesenchymal stem cells’, a steady increase from 24 articles in the year 2000 to 2571 in 2021 (Figure 2).",PMC9255790_figure_2,Figure 2. The number of journal article publications with the keywords ‘mesenchymal stem cells’ in their titles between 2000-2021 in PubMed index.,,./data/PMC9255790/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/a2c62e1ef8a0/bt-03-01-65-g002.jpg
PMC9255790,"By searching clinical trials registered at the US National Library of Medicine (clinicaltrials.gov) that currently contains 401,145 research studies in 50 states in the US and 220 countries all over the world, we identified 1389 studies on ‘MSCs’ (Figure 4).62-64 Among these clinical trials, 421 studies were completed, yet only 10 products were approved for clinical application worldwide (Table 5) and no products were approved by the FDA in the US.",PMC9255790_figure_4,Figure 4. The number of clinical trials registered in the ClinicalTrials.gov with the keywords ‘mesenchymal stem cells’ in the title.,,./data/PMC9255790/images/figure_4.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/9c2219b919ad/bt-03-01-65-g004.jpg
PMC9255790,The prospective manufacturing process shown in Figure 5 can be as follows:.,PMC9255790_figure_5,"Figure 5. The proposed manufacturing process. Scaffold is produced, then seeded with cells. When these cells osteogenically differentiate they will express growth factors such as BMP, which will remain on the scaffold after decellularisa-tion. 3D: three-dimensional; BMP: bone morphogenic proteins.",,./data/PMC9255790/images/figure_5.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e426/9255790/b94375d4374b/bt-03-01-65-g005.jpg
